APL-2, A Complement C3 Inhibitor, Slows The Growth Of Geographic Atrophy Secondary To AMD: 18-Month Results (RS 2018) - Apellis Medical Hub Canada

APL-2, A Complement C3 Inhibitor, Slows The Growth Of Geographic Atrophy Secondary To AMD: 18-Month Results

Share Via Email

Back to Conference Resources

GA Congress Presentations Retina Society 2018

The following information is available for educational purposes only. The information is not to be re-purposed or re-used in its current form or presentation for any personal or professional use. Apellis reserves the right to withdraw, modify or change the information that is available on this website at any time.